The prevalence of components of metabolic syndrome in the patients with diabetes melitus type 2 and mody diabetes in young people of Novosibirsk


Cite item

Full Text

Abstract

Aim. To estimate the prevalence of type 2 diabetes mellitus (DM2) and MODY diabetes as well as the prevalence of metabolic syndrome (MS) components for these types of diabetes in the young population of the city of Novosibirsk. Materials and methods. In 2013-2017 years a population survey was conducted of a random representative sample of the population of 25-45 years of both sexes, residents of one of the typical districts of Novosibirsk. WHO criteria (1999-2013) were used for the diagnosis of diabetes: fasting blood glucose ≥7.0 mmol / l after an 8-hour fasting. Also group with DM2 included persons with a fasting blood glucose level <7.0 mmol / l at the time of the research but they indicated that have DM2 and received a hypoglycemic therapy according to the disease. All patients had a clinical examination including measurement of anthropometric parameters, blood pressure, determination of the lipid spectrum in biochemical blood analysis. Molecular genetic research was performed for patients with debut diabetes at the age of 25-45 years and with phenotypic signs of monogenic forms of diabetes (MODY diabetes) in 2014-2017 years. Results and discussion. The prevalence of DM2 was 2.4% among the residents of 25-45 years old in the city of Novosibirsk (n = 32), it was higher among men (3.4%, n = 21), than among women (1.5%, n = 11, p = 0.02) according to the population screening data for 2013-2017. The prevalence of abdominal obesity (AO) was 50%, hypertriglyceridemia (HTG) 35%, arterial hypertension (AH) 70% in the DM2 group. The prevalence of MODY diabetes was 33.3% among patients with a debut of the disease of 25-45 years and phenotypic signs of this nosology. HTG is defined in 31.6% of patients with MODY diabetes; AH - in 31.6%. The conclusion. 2.2% of patients had DM2 among the adult population of Novosibirsk (25-45 years) in 2013-2017. The prevalence of MS components such as AH, AO and HTG is significantly higher in persons with diabetes than in the population sample without DM. Every third patient aged 25-44 years with diabetes "not of the first type" had MODY diabetes in 2014-2017. The prevalence of HTG is comparable among young patients with DM2 and MODY.

About the authors

S V Mustafina

Research Institute of Internal and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences

д.м.н., с.н.с. лаб. клинико-популяционных и профилактических исследований терапевтических и эндокринных заболеваний; ORCID: 0000-0003-4716-876X Novosibirsk, Russia

A K Ovsyannikova

Research Institute of Internal and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences

Email: aknikolaeva@bk.ru
к.м.н., н.с. лаб. клинико-популяционных и профилактических исследований терапевтических и эндокринных заболеваний; ORCID: 0000-0002-9669-745X Novosibirsk, Russia

M I Voevoda

Research Institute of Internal and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences

акад. РАН, д.м.н., проф., руководитель НИИТПМ; ORCID: 0000-0001-9425-413X Novosibirsk, Russia

D V Denisova

Research Institute of Internal and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences

д.м.н., в.н.с. лаб. профилактической медицины; ORCID: 0000-0002-2470-2133 Novosibirsk, Russia

L V Sherbakova

Research Institute of Internal and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences

с.н.с. лаб. клинико-популяционных и профилактических исследований терапевтических и эндокринных заболеваний; ORCID: 0000-0001-9270-9188 Novosibirsk, Russia

O D Rymar

Research Institute of Internal and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences

д.м.н., зав. лаб. клинико-популяционных и профилактических исследований терапевтических и эндокринных заболеваний; ORCID: 0000-0003-4095-016 Novosibirsk, Russia

References

  1. IDF Diabetes Atlas. Eighth edition. 2017;147. Available from: http://www.diabetesatlas.org/resources/2017-atlas.html
  2. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016;19(2):104-112. doi: 10.14341/dm2004116-17
  3. Зубкова Н.А., Арбатская Н.Ю., Петряйкина Е.Е., Малиевский О.А., Тюльпаков А.Н. Сахарный диабет типа MODY3: клиническая и молекулярно - генетическая характеристика 9 случаев заболевания. Проблемы эндокринологии. 2014;(1):51-56. doi: 10.14341/probl201460151-56
  4. Петеркова В.А., Кураева Т.Л., Прокофьев С.А., Емельянов А.О., Захарова Е.Ю., Цыганкова П.Г., Гришина Д.П. Молекулярная генетика и клинические особенности моногенных форм сахарного диабета. Вестник РАМН. 2012;(1):81-86.
  5. Воевода М.И., редактор. Клинико - генетические аспекты MODY диабета. Новосибирск: Издательство Сибирского отделения Российской Академии Наук; 2015.
  6. Mc Donald T.J, Ellard S. Maturity onset diabetes of the young: Identification and diagnosis. Ann Clin Biochem. 2013;50(Pt 5):403-415. doi: 10.1177/0004563213483458
  7. Bonnefond A, Philippe J, Durand E, Dechaume A, Huyvaert M, Montagne L, et al. Whole - exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoSOne. 2012;7(6):e37423. doi: 10.1371/journal.pone.0037423
  8. Delvecchio M, Ludovico O, Menzaghi C, Paola R.D,Zelante L, et al. Low Prevalence of HNF1A Mutations After Molecular Screening of Multiple MODY Genes in 58 Italian Families Recruited in the Pediatric or Adult Diabetes Clinic From a Single Italian Hospital. Diabetes Care. 2014;37:258-260. doi: 10.2337/dc14-1788
  9. Никитин Ю.П., редактор. Cахарный диабет в практике врача - терапевта: распространенность и качество диагностики. Новосибирск: Академическое издательство «Гео»; 2016. С. 579-589.
  10. Кунцевич А.К., Мустафина С.В., Малютина С.К., Веревкин Е.Г., Рымар О.Д. Популяционное исследование питания городского населения при сахарном диабете 2 типа. Сахарный диабет. 2015;18(4):59-65. doi: 10.14341/dm7174
  11. Gow M.L, Garnett S.P, Baur L.A, Lister N.B. The Effectiveness of Different Diet Strategies to reduce 2 Diabetes risk in Youth. Nutrients. 2016;8:486-498. doi: 10.3390/nu8080486
  12. Dedov I, Shestakova M, Massi Benedetti M, Simon D, Pakhomov I, Galstyan G. Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study). Diabet Res Clin Pract. 2016;15:90-95. doi: 10.1016/j.diabres.2016.02.010
  13. Воевода М.И., Ковалькова Н.А., Рагино Ю.А., Травникова Н.Ю., Денисова Д.В. Распространенность метаболического синдрома у жителей Новосибирска в возрасте от 25 до 45 лет. Терапевтический архив. 2016;10(88):51-56. doi: 10.17116/terarkh2016881051-56
  14. Fendler W, Borowiec M, Baranowska-Jazwiecka A, Szadkowska A, et al. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia. 2012;55:2631-2635. doi: 10.1007/s00125-012-2621-2

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies